Mecanismos moleculares de factores de riesgo en cáncer de próstata
Molecular mechanisms of risk factors in prostate cancer
Palabras clave:
Etiología, carcinogénisis, nutrición, ambiente, sistema inmune, inflamación, hormonas sexualesResumen
La incidencia del cáncer de próstata presenta diferencias regionales, probablemente debidas a diferencias en la exposición a factores de riesgo. Varios estudios han relacionado el riesgo de cáncer de próstata con diversos factores, los cuales cumplen un papel importante en la etiopatogenia, estos incluyen factores nutricionales, ambientales y constitucionales. Los efectos pueden manifestarse a través de varios mecanismos que incluyen inflamación, desregulación de hormonas sexuales y supresión del sistema inmune. Se realiza una revisión descriptiva de los principales mecanismos moleculares y sus efectos en la carcinogénesis de próstata.
Citas
Ardura, J. A., Álvarez-Carrión, L., Gutiérrez-Rojas, I. y Alonso, V. (2020). Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms. Cancers, 12(5), 1071. https://doi.org/10.3390/cancers12051071
Bhardwaj, A., Srivastava, S. K., Khan, M. A., Prajapati, V. K., Singh, S., Carter, J. E. y Singh, A. P. (2017). Racial disparities in prostate cancer: a molecular perspective. Frontiers in bioscience (Landmark edition), 22(5), 772–782. https://doi.org/10.2741/4515
Bui, N. N., Li, C. Y., Wang, L. Y., Chen, Y. A., Kao, W. H., Chou, L. F., Hsieh, J. T., Lin, H. y Lai, C. H. (2023). Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 56(2), 246–256. https://doi.org/10.1016/j.jmii.2022.12.009
Chowdhury-Paulino, I. M., Ericsson, C., Vince, R., Jr, Spratt, D. E., George, D. J. y Mucci, L. A. (2022). Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate cancer and prostatic diseases, 25(3), 397-402. https://doi.org/10.1038/s41391-021-00451-z
Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F. y Jemal, A. (2020). Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. European urology, 77(1), 38–52. https://doi.org/10.1016/j.eururo.2019.08.005
Desai, K., McManus, J. M. y Sharifi, N. (2021). Hormonal Therapy for Prostate Cancer. Endocrine reviews, 42(3), 354–373. https://doi.org/10.1210/endrev/bnab002
Dovey, Z. S., Nair, S. S., Chakravarty, D. y Tewari, A. K. (2021). Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies. Cancer reports (Hoboken, N.J.), 4(5), e1340. https://doi.org/10.1002/cnr2.1340
Epstein, J. I., Allsbrook, W. C., Jr, Amin, M. B., Egevad, L. L. y ISUP Grading Committee (2005). The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. The American journal of surgical pathology, 29(9), 1228–1242. https://doi.org/10.1097/01.pas.0000173646.99337.b1
Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., Bray, F. (2024). Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today
Friedenreich, C. M., Ryder-Burbidge, C. y McNeil, J. (2021). Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Molecular oncology, 15(3), 790–800. https://doi.org/10.1002/1878-0261.12772
Goswami, S., Sarkar, C., Singh, S., Singh, A. P. y Chakroborty, D. (2022). Racial differences in prostate tumor microenvironment: implications for disparate clinical outcomes and potential opportunities. Cancer health disparities, 6, 214.
Haffner, M. C., Zwart, W., Roudier, M. P., True, L. D., Nelson, W. G., Epstein, J. I., De Marzo, A. M., Nelson, P. S. y Yegnasubramanian, S. (2021). Genomic and phenotypic heterogeneity in prostate cancer. Nature reviews. Urology, 18(2), 79–92. https://doi.org/10.1038/s41585-020-00400-w
Hinata, N. y Fujisawa, M. (2022). Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview. The world journal of men's health, 40(2), 217–227. https://doi.org/10.5534/wjmh.210070
Hong, S., Khil, H., Lee, D. H., Keum, N. y Giovannucci, E. L. (2020). Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis. Nutrients, 12(8), 2188. https://doi.org/10.3390/nu12082188
Ittmann, M. (2018). Anatomy and Histology of the Human and Murine Prostate. Cold Spring Harbor perspectives in medicine, 8(5), a030346. https://doi.org/10.1101/cshperspect.a030346
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. y Thun, M. J. (2009). Cancer statistics, 2009. CA: a cancer journal for clinicians, 59(4), 225–249. https://doi.org/10.3322/caac.20006
Joseph, D. B., Henry, G. H., Malewska, A., Iqbal, N. S., Ruetten, H. M., Turco, A. E., Abler, L. L., Sandhu, S. K., Cadena, M. T., Malladi, V. S., Reese, J. C., Mauck, R. J., Gahan, J. C., Hutchinson, R. C., Roehrborn, C. G., Baker, L. A., Vezina, C. M. y Strand, D. W. (2020). Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. The Prostate, 80(11), 872–884. https://doi.org/10.1002/pros.24020
Khan, H. M., & Cheng, H. H. (2022). Germline genetics of prostate cancer. The Prostate, 82 Suppl 1(Suppl 1), S3–S12. https://doi.org/10.1002/pros.24340
Kobelyatskaya, A. A., Pudova, E. A., Snezhkina, A. V., Fedorova, M. S., Pavlov, V. S., Guvatova, Z. G., Savvateeva, M. V., Melnikova, N. V., Dmitriev, A. A., Trofimov, D. Y., Sukhikh, G. T., Nyushko, K. M., Alekseev, B. Y., Razin, S. V., Krasnov, G. S., & Kudryavtseva, A. V. (2021). Impact TMPRSS2-ERG Molecular Subtype on Prostate Cancer Recurrence. Life (Basel, Switzerland), 11(6), 588. https://doi.org/10.3390/life11060588
Koga, Y., Song, H., Chalmers, Z. R., Newberg, J., Kim, E., Carrot-Zhang, J., Piou, D., Polak, P., Abdulkadir, S. A., Ziv, E., Meyerson, M., Frampton, G. M., Campbell, J. D. y Huang, F. W. (2020). Genomic Profiling of Prostate Cancers from Men with African and European Ancestry. Clinical cancer research: an official journal of the American Association for Cancer Research, 26(17), 4651–4660. https://doi.org/10.1158/1078-0432.CCR-19-4112
Kohaar, I., Li, Q., Chen, Y., Ravindranath, L., Young, D., Ali, A., Sesterhenn, I. A., Rosner, I. L., Cullen, J., Srivastava, S., Freedman, M. y Petrovics, G. (2020). Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer. Oncotarget, 11(15), 1321–1333. https://doi.org/10.18632/oncotarget.27534
Lawson, J. S. y Glenn, W. K. (2022). Multiple pathogens and prostate cancer. Infectious agents and cancer, 17(1), 23. https://doi.org/10.1186/s13027-022-00427-1
Lillard, J. W., Jr, Moses, K. A., Mahal, B. A. y George, D. J. (2022). Racial disparities in Black men with prostate cancer: A literature review. Cancer, 128(21), 3787–3795. https://doi.org/10.1002/cncr.34433
Lowder, D., Rizwan, K., McColl, C., Paparella, A., Ittmann, M., Mitsiades, N. y Kaochar, S. (2022). Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics. Cancer letters, 531, 71–82. https://doi.org/10.1016/j.canlet.2022.01.028
Macke, A. J. y Petrosyan, A. (2022). Alcohol and Prostate Cancer: Time to Draw Conclusions. Biomolecules, 12(3), 375. https://doi.org/10.3390/biom12030375
Mahal, B. A., Alshalalfa, M., Kensler, K. H., Chowdhury-Paulino, I., Kantoff, P., Mucci, L. A., Schaeffer, E. M., Spratt, D., Yamoah, K., Nguyen, P. L. y Rebbeck, T. R. (2020). Racial Differences in Genomic Profiling of Prostate Cancer. The New England journal of medicine, 383(11), 1083–1085. https://doi.org/10.1056/NEJMc2000069
Matsushita, M., Fujita, K. y Nonomura, N. (2020). Influence of Diet and Nutrition on Prostate Cancer. International journal of molecular sciences, 21(4), 1447. https://doi.org/10.3390/ijms21041447
Matsushita, M., Fujita, K., Hatano, K., De Velasco, M. A., Tsujimura, A., Uemura, H. y Nonomura, N. (2023). Emerging Relationship between the Gut Microbiome and Prostate Cancer. The world journal of men's health, 41(4), 759–768. https://doi.org/10.5534/wjmh.220202
Ni Raghallaigh, H. y Eeles, R. (2022). Genetic predisposition to prostate cancer: an update. Familial cancer, 21(1), 101–114. https://doi.org/10.1007/s10689-021-00227-3
Nouri-Majd, S., Salari-Moghaddam, A., Aminianfar, A., Larijani, B. y Esmaillzadeh, A. (2022). Association Between Red and Processed Meat Consumption and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers in nutrition, 9, 801722. https://doi.org/10.3389/fnut.2022.801722
Nuru, F., Osei, E. y Kassim, R. (2022). A review of the effects of tobacco smoking on the treatment of prostate cancer. Journal of Radiotherapy in Practice, 21(1), 109-116.https://dx.doi.org/10.1017/S1460396920000552
Oczkowski, M., Dziendzikowska, K., Pasternak-Winiarska, A., Włodarek, D. y Gromadzka-Ostrowska, J. (2021). Dietary Factors and Prostate Cancer Development, Progression, and Reduction. Nutrients, 13(2), 496. https://doi.org/10.3390/nu13020496
Poulson, M. R., Helrich, S. A., Kenzik, K. M., Dechert, T. A., Sachs, T. E. y Katz, M. H. (2021). The impact of racial residential segregation on prostate cancer diagnosis and treatment. BJU international, 127(6), 636–644. https://doi.org/10.1111/bju.15293
Powell, I. J., Chinni, S. R., Reddy, S. S., Zaslavsky, A. y Gavande, N. (2021). Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update. Urologic oncology, 39(1), 34–40. https://doi.org/10.1016/j.urolonc.2020.08.019
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T. y Bristow, R. G. (2021). Prostate cancer. Nature reviews. Disease primers, 7(1), 9. https://doi.org/10.1038/s41572-020-00243-0
Sandhu, S., Moore, C. M., Chiong, E., Beltran, H., Bristow, R. G. y Williams, S. G. (2021). Prostate cancer. Lancet (London, England), 398(10305), 1075–1090. https://doi.org/10.1016/S0140-6736(21)00950-8
Scheinberg, T., Mak, B., Butler, L., Selth, L. y Horvath, L. G. (2023). Targeting lipid metabolism in metastatic prostate cancer. Therapeutic advances in medical oncology, 15, 17588359231152839. https://doi.org/10.1177/17588359231152839
Stopsack, K. H., Nandakumar, S., Arora, K., Nguyen, B., Vasselman, S. E., Nweji, B., McBride, S. M., Morris, M. J., Rathkopf, D. E., Slovin, S. F., Danila, D. C., Autio, K. A., Scher, H. I., Mucci, L. A., Solit, D. B., Gönen, M., Chen, Y., Berger, M. F., Schultz, N., Abida, W., … Kantoff, P. W. (2022). Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors. Clinical cancer research: an official journal of the American Association for Cancer Research, 28(2), 318–326. https://doi.org/10.1158/1078-0432.CCR-21-25
Yuan, J., Kensler, K. H., Hu, Z., Zhang, Y., Zhang, T., Jiang, J., Xu, M., Pan, Y., Long, M., Montone, K. T., Tanyi, J. L., Fan, Y., Zhang, R., Hu, X., Rebbeck, T. R. y Zhang, L. (2020). Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry. PLoS genetics, 16(2), e1008641. https://doi.org/10.1371/journal.pgen.1008641
Yu, X., Liu, R., Song, L., Gao, W., Wang, X. y Zhang, Y. (2023). Differences in the pathogenetic characteristics of prostate cancer in the transitional and peripheral zones and the possible molecular biological mechanisms. Frontiers in oncology, 13, 1165732. https://doi.org/10.3389/fonc.2023.1165732
Zuniga, K. B., Chan, J. M., Ryan, C. J. y Kenfield, S. A. (2020). Diet and lifestyle considerations for patients with prostate cancer. Urologic oncology, 38(3), 105–117. https://doi.org/10.1016/j.urolonc.2019.06.018
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Alexis Sayuri Suarez-Villanueva, José Miguel Moreno-Ortiz , Ruth Ramírez-Ramírez
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
